CDH1 and hepatocellular carcinoma: In a meta-analysis by Chen et al., an overall reduction in E-cadherin expression was associated with an unfavorable prognosis in HCC; however, the percentage of HCC with reduced expression of E-cadherin in the selected studies had a variance between 1.6% and 76.2%.